Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
7.44
-0.28 (-3.63%)
At close: Apr 28, 2026, 4:00 PM EDT
7.30
-0.14 (-1.88%)
After-hours: Apr 28, 2026, 6:18 PM EDT
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 55 employees as of December 31, 2025. The number of employees increased by 10 or 22.22% compared to the previous year.
Employees
55
Change (1Y)
10
Growth (1Y)
22.22%
Revenue / Employee
n/a
Profits / Employee
-$1,383,927
Market Cap
495.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Lyell Immunopharma | 300 |
| Kyverna Therapeutics | 130 |
| Adlai Nortye | 109 |
| Verastem | 102 |
| Upstream Bio | 75 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
FULC News
- 1 day ago - Fulcrum Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 1 day ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 - GlobeNewsWire
- 1 day ago - Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors - GlobeNewsWire
- 8 days ago - Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET - GlobeNewsWire
- 5 weeks ago - MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease - GlobeNewsWire
- 7 weeks ago - Fulcrum Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference - GlobeNewsWire